---
title: "The innovative drug concept has repeatedly strengthened, and Qianhong Bio-pharma has surged to the limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247906874.md"
description: "36Kr learned that as of the time of publication, the innovative drug concept has repeatedly strengthened, Qianhong Bio-pharma surged and hit the limit up, Thalys, JLPC, C&Y Pharmaceutical, and Haizhi Ke all reached the limit up, while HWPC rose over 10%, setting a new historical high for its stock price"
datetime: "2025-07-10T02:16:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247906874.md)
  - [en](https://longbridge.com/en/news/247906874.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247906874.md)
---

# The innovative drug concept has repeatedly strengthened, and Qianhong Bio-pharma has surged to the limit

36Kr learned that as of the time of publication, the innovative drug concept has repeatedly strengthened, Qianhong Bio-pharma surged to the limit, Thalys, JLPC, C&Y Pharmaceutical, and Haikang all hit the daily limit, while HWPC rose over 10%, reaching a historical high

### Related Stocks

- [688799.CN](https://longbridge.com/en/quote/688799.CN.md)
- [603716.CN](https://longbridge.com/en/quote/603716.CN.md)
- [002550.CN](https://longbridge.com/en/quote/002550.CN.md)
- [600513.CN](https://longbridge.com/en/quote/600513.CN.md)
- [300254.CN](https://longbridge.com/en/quote/300254.CN.md)

## Related News & Research

- [11:16 ETHaier ist die einzige IoT-Ökosystemmarke der Welt, die acht Jahre in Folge in die Kantar BrandZ Top 100 aufgenommen wurde](https://longbridge.com/en/news/286792596.md)
- [Dahlonega Now a ‘Gig-Ready’ Community from Kinetic’s Fiber-Optic Network Expansion](https://longbridge.com/en/news/287079090.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)